
HCA Healthcare (HCA) Stock Forecast & Price Target
HCA Healthcare (HCA) Analyst Ratings
Bulls say
HCA Healthcare is a leader in the hospital industry with a strong management team, consistent growth trends, and impressive margins. The company's strong track record of operational performance and continued market share gains in faster-growing markets make it a premier healthcare provider. Factors such as state supplemental payments and tracking of unpaid premiums from exchange patients further support our positive outlook on the company. Our price target of $520 reflects a premium valuation, but is supported by the company's strong fundamentals, including a diverse board and workforce and a focus on sustainability. Higher-than-expected approvals for state-directed payments and continued cost controls could provide further upside to our target price.
Bears say
HCA Healthcare is facing several challenges, including a recent decline in same-facility admissions and outpatient surgeries, primarily due to the impact of weather and respiratory illnesses. The company's financials were also affected by changes in state supplemental payments and weaker respiratory season. Additionally, HCA Healthcare may face pressure from increased competition and tightening labor markets in certain regions. These factors contribute to the negative outlook on the stock's performance.
This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.
HCA Healthcare (HCA) Analyst Forecast & Price Prediction
Start investing in HCA Healthcare (HCA)
Order type
Buy in
Order amount
Est. shares
0 shares